Safety and efficacy of glecaprevir/pibrentasvir for the treatment of HCV genotype 1-6: results from the HCV-TARGET study

Sterling RK, Zeuzem S, Wetzel T, et al. Safety and efficacy of glecaprevir/pibrentasvir for the treatment of HCV genotype 1-6: results from the HCV-TARGET study. International Liver Congress. Vienna, Austria; 2019.

Publication Type:

Conference Proceedings

Authors:

Sterling, RK; Zeuzem, S; Wetzel, T; et, al

Source:

International Liver Congress, Vienna, Austria (2019)

Cited On:

Export Citation:
RIS Format
Top